P. Kelly et al., Impaired bioavailability of vitamin A in adults and children with persistent diarrhoea in Zambia, ALIM PHARM, 15(7), 2001, pp. 973-979
Background: We have previously demonstrated a strong relationship between l
ow serum retinol concentration and mortality in Zambian AIDS patients with
diarrhoea, but were unable to detect any benefit from oral micronutrient su
pplementation.
Aim: To test the hypothesis that this is related to impaired availability o
f vitamin A, we analysed serum retinol concentration changes over 6 h follo
wing oral mega-dose therapy (60, 120 or 180 mg retinol).
Methods: Twenty-four men without diarrhoea, 15 adults with persistent diarr
hoea and 11 children (six girls, five boys) with persistent diarrhoea were
studied.
Results: Men with persistent diarrhoea had lower baseline serum retinol con
centrations (median 0.39 mu mol/L, interquartile range 0.21-0.56) than cont
rols (median 1.16 mu mol/L, interquartile range 0.84-1.47; P = 0.0003). Aft
er 60 mg retinol, the rise in serum retinol in HIV seropositive controls (m
edian 0.63 mu mol/L, interquartile range 0.35-0.77) did not differ signific
antly from that observed in HIV seronegative controls (median 0.35 mu mol/L
, interquartile range - 0.04-0.56; P = 0.20). Increasing the dose to 120 mg
or 180 mg retinol did not enhance the increase in serum retinol concentrat
ion. The increase in serum retinol was less in adults with persistent diarr
hoea (median 0.25 mu mol/L, interquartile range 0.04-0.35) and in children
(median 0.11 mu mol/L, interquartile range 0.04-0.46) than in men without d
iarrhoea (median 0.44 mu mol/L, interquartile range 0.26-0.74; P = 0.03). A
dults and children with diarrhoea had greater losses of retinol in urine ov
er a 24-h period than controls, but less than 1% of the ingested dose was e
xcreted.
Conclusions: These results suggest that persistent diarrhoea in this popula
tion is associated with reduced bioavailability of retinol. Further work is
required to determine the metabolic fate of therapeutic doses of retinol a
nd to determine appropriate replacement strategies for HIV infected individ
uals.